Silexion Therapeutics Corp Ordinary Shares (SLXN)
Stock · NASDAQ · Health Care
$0.363as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About SLXN
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of panc…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 13
- Website
- silexion.com
Fundamentals
- 1-day range
- $0.373$0.4202
- Market cap
- $2.07M
- P/E (trailing)
- —
- P/E (forward)
- -0.66
- EPS (trailing)
- $-59.70
- Dividend yield
- —
- Beta
- -0.27
- Avg. volume
- 803.5K
Forecasts
1 analyst ratings
Silexion Therapeutics Corp Ordinary Shares Competitors
Chosen by industry and closest market cap.
- SLXNSilexion Therapeutics Corp Ordinary Shares$0.363▲ 0.83%Market cap $2.07MP/E —$0.373$80
- SCNIScinai Immunotherapeutics Ltd. American Depositary Shares$2.53▼ 5.60%Market cap $1.37MP/E 0.14$2.15$16.8
- VIVSVivoSim Labs Inc. Common Stock$0.29▲ 0.00%Market cap $4.03MP/E —$0.2625$5.3
- PHGEBiomX Inc. COmmon Stock$0.138▲ 4.55%Market cap $4.62MP/E —$0.1192$12.29
- BCABBioAtla Inc. Common Stock$1.79▼ 42.99%Market cap $5.41MP/E —$2.81$71.5
- AIMAIM ImmunoTech Inc. Common Stock$0.2558▲ 2.32%Market cap $7.32MP/E —$0.1901$2.89
- BCDABioCardia Inc. Common Stock$1.16▼ 0.85%Market cap $9.45MP/E —$0.75$2.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SLXN Silexion Therapeutics Corp Ordinary Shares | $2.07M | — | $0.363 | ▲ 0.83% | $0.373$80 |
| SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares | $1.37M | 0.14 | $2.53 | ▼ 5.60% | $2.15$16.8 |
| VIVS VivoSim Labs Inc. Common Stock | $4.03M | — | $0.29 | ▲ 0.00% | $0.2625$5.3 |
| PHGE BiomX Inc. COmmon Stock | $4.62M | — | $0.138 | ▲ 4.55% | $0.1192$12.29 |
| BCAB BioAtla Inc. Common Stock | $5.41M | — | $1.79 | ▼ 42.99% | $2.81$71.5 |
| AIM AIM ImmunoTech Inc. Common Stock | $7.32M | — | $0.2558 | ▲ 2.32% | $0.1901$2.89 |
| BCDA BioCardia Inc. Common Stock | $9.45M | — | $1.16 | ▼ 0.85% | $0.75$2.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Silexion Therapeutics Q2 EPS $(5.17) Misses $(2.12) EstimateBenzinga · 8/14/2026
- Let's take a look at the stocks that are in motion in today's session.ChartMill · 8/12/2026
- Here are the top movers in Wednesday's session.ChartMill · 8/12/2026
- The market is filled with gapping stocks in Wednesday's session.ChartMill · 8/12/2026
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 8/12/2026
- Wondering what's happening in today's pre-market session?ChartMill · 8/12/2026
- Nasdaq Surges 150 Points; US Inflation Rate Slows To 3.4% In JulyBenzinga · 8/12/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 8/12/2026
Insider Activity
Insider Actions →- Horenshtein Hadar Mirit · June 4, 2026 · Grant7.5K
- Shirvan Mitchell · June 4, 2026 · Grant6.0K
- Hadar Ilan · June 4, 2026 · Grant10.0K
- Shirvan Mitchell · March 26, 2026 · Sale22.8K @ $1.36
See the full, filterable feed with live charts on the MarketWall dashboard.